Alan Meds vs Näky
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Näky
Best for patients comfortable with intake-gated pricing who want access to compounded oral semaglutide drops or an explicit microdose program alongside a longevity menu (NAD+ / Sermorelin)Side-by-Side Comparison
| Feature | Alan Meds | Näky |
|---|---|---|
| Overall Score | ✓7.7/10 | 7.0/10 |
| Starting Price | $99/mo | — |
| Editorial Rating | ✓3.9 ★ /5 | 3.5 ★ /5 |
| Features | 5 features | ✓9 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Näky
Pros
- ✓LegitScript Approved seal verbatim displayed ('Verify LegitScript Approval for www.benaky.com')
- ✓Oral semaglutide DROPS as a distinct product line — uncommon among compounded GLP-1 telehealth
- ✓Explicit GLP-1 Microdose program offered as a separate SKU
- ✓Multi-modality menu (NAD+, Sermorelin) for patients seeking longevity stack alongside GLP-1
- ✓3-minute online assessment + same-day treatment plan disclosed publicly
- ✓NAKY10 promo code referenced for oral semaglutide product line
Cons
- ✗Steady-state monthly pricing for compounded semaglutide and tirzepatide NOT disclosed publicly — gated behind intake
- ✗Oral semaglutide drops pricing NOT disclosed
- ✗GLP-1 Microdose program pricing NOT disclosed
- ✗Specific legal entity name + state of incorporation NOT publicly disclosed
- ✗Partner FDA-regulated pharmacy name NOT disclosed (only generic 'USA Based FDA-Regulated pharmacies' claim)
- ✗Per-state availability NOT enumerated
- ✗Brand-name GLP-1 lineup (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) NOT addressed — compounded only
- ✗/treatments/<slug> and /pricing routes return 404 — pricing tiers genuinely intake-gated
- ✗Initial consultation fee structure NOT disclosed publicly
- ✗Lab work + ongoing-care touchpoints NOT clearly disclosed in marketing copy
- ✗**Oral semaglutide DROPS** are not the same as Rybelsus or any FDA-approved oral semaglutide formulation — patients should ask for specific bioavailability + dose-equivalence framing during the intake; we do not endorse compounded oral GLP-1 drops as bioequivalent to FDA-approved alternatives without primary-source verification
Our Verdict
Alan Meds edges out Näky with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Näky remains a solid alternative, especially if you're looking for patients comfortable with intake-gated pricing who want access to compounded oral semaglutide drops or an explicit microdose program alongside a longevity menu (NAD+ / Sermorelin).
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.